일요일, 5월 19, 2024
HomeWomen's HealthCongressional Briefing: Stopping HPV-Associated Cancers By way of Vaccination and Screening

Congressional Briefing: Stopping HPV-Associated Cancers By way of Vaccination and Screening



Cancers brought on by human papillomavirus (HPV), which embody cervical, throat, head, neck, anal, penile and vaginal, stay a big public well being downside in the USA. Cervical most cancers is the fourth most typical most cancers in girls worldwide and an estimated 4,300 deaths from cervical most cancers will happen in 2023 within the U.S.

Thankfully, along with important screening and early remedy, there’s an HPV vaccine that protects in opposition to the varieties of HPV that trigger most cervical and different HPV-associated cancers. This vaccine is a serious development because it presents major prevention in opposition to the infectious agent that’s the predominant reason for HPV-related cancers. Knowledge demonstrates that HPV vaccination might stop greater than 90% of HPV-caused cancers.

Regardless of the demonstrated success of screening and the HPV vaccine, vaccination and screening charges nonetheless fall beneath nationwide targets, and solely worsened throughout the pandemic.

Be a part of our Congressional Briefing: Stopping HPV-Associated Cancers By way of Vaccination and Screening to learn the way the HPV vaccine, screening and early remedy are highly effective instruments to assist finish a number of cancers and what actions Congress can take to assist obtain elevated uptake of those modalities all through the nation.

RELATED ARTICLES
RELATED ARTICLES

Most Popular